vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and indie Semiconductor, Inc. (INDI). Click either name above to swap in a different company.

indie Semiconductor, Inc. is the larger business by last-quarter revenue ($55.5M vs $38.9M, roughly 1.4× CODEXIS, INC.). On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 2.6%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 2.9%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.

CDXS vs INDI — Head-to-Head

Bigger by revenue
INDI
INDI
1.4× larger
INDI
$55.5M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+78.8% gap
CDXS
81.3%
2.6%
INDI
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
2.9%
INDI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
INDI
INDI
Revenue
$38.9M
$55.5M
Net Profit
$9.6M
Gross Margin
94.8%
38.0%
Operating Margin
27.1%
-70.1%
Net Margin
24.7%
Revenue YoY
81.3%
2.6%
Net Profit YoY
192.5%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
INDI
INDI
Q1 26
$55.5M
Q4 25
$38.9M
$58.0M
Q3 25
$8.6M
$53.7M
Q2 25
$15.3M
$51.6M
Q1 25
$7.5M
$54.1M
Q4 24
$21.5M
$58.0M
Q3 24
$12.8M
$54.0M
Q2 24
$8.0M
$52.4M
Net Profit
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
$9.6M
$-31.2M
Q3 25
$-19.6M
$-38.3M
Q2 25
$-13.3M
$-39.0M
Q1 25
$-20.7M
$-34.5M
Q4 24
$-10.4M
$-34.4M
Q3 24
$-20.6M
$-49.7M
Q2 24
$-22.8M
$-19.2M
Gross Margin
CDXS
CDXS
INDI
INDI
Q1 26
38.0%
Q4 25
94.8%
37.3%
Q3 25
71.3%
40.1%
Q2 25
86.3%
40.6%
Q1 25
63.8%
41.7%
Q4 24
83.0%
42.6%
Q3 24
66.4%
39.3%
Q2 24
56.6%
42.2%
Operating Margin
CDXS
CDXS
INDI
INDI
Q1 26
-70.1%
Q4 25
27.1%
-58.5%
Q3 25
-220.3%
-71.4%
Q2 25
-83.9%
-83.3%
Q1 25
-271.6%
-72.0%
Q4 24
-34.2%
-58.4%
Q3 24
-129.0%
-92.5%
Q2 24
-284.9%
-70.0%
Net Margin
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
24.7%
-53.8%
Q3 25
-228.1%
-71.3%
Q2 25
-86.6%
-75.6%
Q1 25
-274.3%
-63.9%
Q4 24
-48.4%
-59.2%
Q3 24
-160.8%
-92.1%
Q2 24
-285.2%
-36.6%
EPS (diluted)
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
$0.13
$-0.16
Q3 25
$-0.22
$-0.19
Q2 25
$-0.16
$-0.20
Q1 25
$-0.25
$-0.18
Q4 24
$-0.12
$-0.18
Q3 24
$-0.29
$-0.28
Q2 24
$-0.32
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
INDI
INDI
Cash + ST InvestmentsLiquidity on hand
$78.2M
$174.4M
Total DebtLower is stronger
$40.1M
$402.8M
Stockholders' EquityBook value
$50.5M
$348.9M
Total Assets
$147.8M
$869.6M
Debt / EquityLower = less leverage
0.79×
1.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
INDI
INDI
Q1 26
$174.4M
Q4 25
$78.2M
$145.5M
Q3 25
$58.7M
$160.9M
Q2 25
$66.3M
$192.6M
Q1 25
$59.8M
$236.6M
Q4 24
$73.5M
$274.2M
Q3 24
$90.3M
$96.9M
Q2 24
$73.2M
$112.3M
Total Debt
CDXS
CDXS
INDI
INDI
Q1 26
$402.8M
Q4 25
$40.1M
$353.4M
Q3 25
$39.7M
$353.5M
Q2 25
$39.4M
$352.5M
Q1 25
$29.2M
$379.0M
Q4 24
$28.9M
$381.3M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
CDXS
CDXS
INDI
INDI
Q1 26
$348.9M
Q4 25
$50.5M
$358.0M
Q3 25
$38.5M
$369.2M
Q2 25
$55.6M
$390.4M
Q1 25
$49.6M
$405.6M
Q4 24
$66.9M
$417.9M
Q3 24
$73.4M
$458.6M
Q2 24
$61.4M
$470.7M
Total Assets
CDXS
CDXS
INDI
INDI
Q1 26
$869.6M
Q4 25
$147.8M
$840.8M
Q3 25
$124.0M
$855.1M
Q2 25
$138.2M
$867.6M
Q1 25
$128.9M
$909.0M
Q4 24
$149.0M
$941.4M
Q3 24
$148.2M
$797.5M
Q2 24
$132.0M
$797.3M
Debt / Equity
CDXS
CDXS
INDI
INDI
Q1 26
1.15×
Q4 25
0.79×
0.99×
Q3 25
1.03×
0.96×
Q2 25
0.71×
0.90×
Q1 25
0.59×
0.93×
Q4 24
0.43×
0.91×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
INDI
INDI
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
$20.1M
$-14.4M
Q3 25
$-7.7M
$-6.2M
Q2 25
$-18.0M
$-7.6M
Q1 25
$-13.8M
$-29.0M
Q4 24
$-16.5M
$-6.7M
Q3 24
$-13.0M
$-22.8M
Q2 24
$-12.2M
$-19.7M
Free Cash Flow
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
$19.6M
$-16.1M
Q3 25
$-7.9M
$-10.3M
Q2 25
$-20.5M
$-13.6M
Q1 25
$-15.1M
$-31.4M
Q4 24
$-18.2M
$-8.6M
Q3 24
$-14.0M
$-29.3M
Q2 24
$-12.6M
$-23.4M
FCF Margin
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
50.3%
-27.8%
Q3 25
-91.7%
-19.2%
Q2 25
-133.6%
-26.4%
Q1 25
-199.6%
-58.0%
Q4 24
-85.0%
-14.8%
Q3 24
-109.0%
-54.3%
Q2 24
-157.5%
-44.7%
Capex Intensity
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
1.3%
3.0%
Q3 25
2.1%
7.8%
Q2 25
16.4%
11.6%
Q1 25
16.7%
4.4%
Q4 24
8.3%
3.2%
Q3 24
7.8%
12.1%
Q2 24
5.0%
7.0%
Cash Conversion
CDXS
CDXS
INDI
INDI
Q1 26
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

INDI
INDI

Product revenue$51.6M93%
Contract revenue$3.9M7%

Related Comparisons